Consideration of C1q and FcRn binding to allotypically disparate IgG3 could aid in engineering more efficacious anti-SARS-CoV-2 mAbs. | Proc Natl Acad Sci U S A;120(22): e2306078120, 2023 05 30. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Consideration of C1q and FcRn binding to allotypically disparate IgG3 could aid in engineering more efficacious anti-SARS-CoV-2 mAbs.

Pandey, Janardan P.

Pandey JP; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC 29425-2230.

Proc Natl Acad Sci U S A ; 120(22): e2306078120, 2023 05 30.

Article in English | MEDLINE | ID: covidwho-20241005

Subject(s)

COVID-19; Immunoglobulin G; Humans; Immunoglobulin G/genetics; Immunoglobulin G/metabolism; Complement C1q; Receptors, Fc/genetics; Receptors, Fc/metabolism; Histocompatibility Antigens Class I/metabolism

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoglobulin G / COVID-19 Limits: Humans Language: English Journal: Proc Natl Acad Sci U S A Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoglobulin G / COVID-19 Limits: Humans Language: English Journal: Proc Natl Acad Sci U S A Year: 2023 Document Type: Article